Jul 20, 2020

Jul 20, 2020

Jul 20, 2020

SECURITY EQUIPMENT MANUFACTURER B O D Y S C A N N E R • Replace PMMA based radome material • Consistent dielectric performance across large sheet/surface area (4mm thick, 2m high) • Ultra low losses • No defects across full surface area • High resolution imaging to show small illegal objects • Formulated a custom material to match customer requirements • Reduced dielectric loss to 0.0009 • Improved image quality of body scanner with uniform dielectric performance and exceptionally low losses • Enabled scan time of 2 seconds and person throughput of 400 persons per hour, compared to 100 person throughput of conventional devices PREPERM™ PPE 260 Formulation KEY REQUIREMENTS WHY AVIENT?

SHEET RAW MATERIAL SUPPLIERS PET BOTTLE PET PREFORM THERMOFORMERS BRAND OWNERS RETAILERS CONSUMERS LOCAL WASTE MANAGEMENT SORTING COMPANIES RECYCLING COMPANIES REGULATION BODIES NIAS COMPLIANT Why is PET so Popular? Sheet & Film—Sheets and films made of PET are another major use case. PET sheets can be used to make a variety of plastic products and film is often used for tape backing, plastic wrap, medical packaging, and protective coating on windows.

● Strong balance sheet and freff e cash flow, as total cash and liquidity ended the year at $227 million and $613 million, respectively. The second independent source of data that we used to augment the peer proxy analysis was the Consultant’s analysis of competitive market data relating to other applicable general industries. The CEOmakes his recommendations in conjunction with the marketplace data.

HEALTHCARE POLYMER SOLUTIONS Mevopur™ Healthcare Colorants & Formulations Mevopur™ Healthcare Functional Additives Sustainability Spotlight Human Health & Safety MITIGATING RISK AT EVERY STAGE OF DESIGN AND PRODUCTION Mevopur™ polymer solutions are trusted products and services developed to help medical device, diagnostics and pharmaceutical packaging sectors meet the growing challenges of product consistency, compliance and reliability. These additive concentrates help reduce material use by up to 20% depending on part geometry and wall thickness and are specially formulated and risk-assessed for healthcare applications.

Expand EBITDA margins to 20% 3. PRIOR YEAR $790 $710 2022 2023 $107 $112 2022 2023 Sales Adjusted EBITDA $0.42 $0.47 2022 PF 2023 - 10% + 5% + 12% Sales Adjusted EBITDA Adjusted EPS 16 $112 $500 $0.47 Q4 AND FULL YEAR 2023 GUIDANCE $710 $3,130 Sales Adjusted EBITDA Adjusted EPS 17 (in millions) (in millions) Guidance: Free Cash Flow $180 $180 Prior Guidance Guidance FREE CASH FLOW & INCREASED DIVIDEND 13th Consecutive Dividend Increase 0.16 0.26 0.42 0.58 0.79 0.85 0.99 1.03 2011 2013 2015 2017 2019 2021 2023 2024 S U S TAI NABI L I T Y DAY RE CAP SUSTAINABILITY AS A GROWTH DRIVERLONG-TERM REVENUE GROWTH DRIVERS 60%+ Key Growth Drivers Sustainable Solutions Composites, Healthcare, Asia / LATAM Overlap Other (GDP Growth) Total Company Revenue Growth Drivers Long-Term Growth Rate Sustainable Solutions 8–12% Composites 8–10% Healthcare 8–10% Asia / LATAM 5% Other (GDP growth) 0–2% Avient 6% SUSTAINABILITY TRENDS DRIVE LONG-TERM GROWTH 8-12% Long Term Growth 50 90 2022 2030 Medical Plastics Market Size (in $Billions) 2020 2030 Recycled Plastics Virgin Plastics Growing Demand for Recycled Content Avient Sustainable Solutions 46 2023 2032 Global Offshore Annual Wind Installations (in Gigawatts) Sources: McKinsey, Bloomberg, Grand View Research SUSTAINABILITY TRENDS DRIVE LONG-TERM GROWTH 21 • Transformative acquisitions combined with divestitures of more cyclical businesses have improved margins over 400 bps since 2018 • 20% long-term margin goal to be driven by key growth drivers, with sustainable solutions playing a meaningful role 5.4% 11.5% 2006 2018 2023E Recovery Growth Drivers Strategic Objective 20%+ +1%+ +3%+ ADJUSTED EBITDA MARGIN EXPANSION 22 • 6% annualized long-term sales growth leveraging sustainable solutions, composites, healthcare, and emerging regions • Expand EBITDA margins to 20% • Deliver annual EBITDA and EPS growth of 10% and 15% • Maintain asset-light, 80% free cash flow conversion profile and be valued as a specialty formulator • Continue fostering our Great Place to Work® culture CREATING A WORLD-CLASS SUSTAINABLE ORGANIZATION 23 PEER COMPARISONS AVIENT IS ASSET LIGHT Capex / Revenue 2023E (%) Avient Specialty Other Specialty / Note: Avient reflects 2023 estimated revenue of $3,130 and estimated run-rate CAPEX of $110M. 26 3.5 1.8 2.7 3.0 3.4 3.7 2.8 3.7 4.6 5.0 6.9 7.0 8.6 11.1 Av ie nt PP PM FM C N C FREE CASH FLOW CONVERSION Note: Free cash flow conversion calculated as (Adjusted EBITDA – Capex) / Adjusted EBITDA. Avient 2011, 2018 and 2021 multiples reflect trailing 12 months EBITDA at December 31. 28 EV / 2023E EBITDA 6.5 8.5 11.0 8.9 12.0 11.9 10.9 9.9 8.2 16.3 13.8 11.9 9.6 9.5 9.5 9.2 7.7 11 21 O ct 23 PM PP FM C C Avient Historic Multiple Avient Specialty Other Specialty / AP P E N DI X 30 Performance Additives 16% Pigments 12% TiO2 Dyestuffs 2% Polyethylene Nylon Polypropylene Styrenic Block Copolymer Other Raw Materials 33% ~40% hydrocarbon based (Grey shaded materials are hydrocarbon based, includes portion of “Other Raw Materials”) Non-hydrocarbon based materials 2022 pro forma results for the acquisition of Avient Protective Materials RAW MATERIAL BASKET SEGMENT DATA U.S. & Canada 40% 37% 18% 2022 PRO FORMA SEGMENT, END MARKET AND GEOGRAPHY GEOGRAPHY REVENUESEGMENT FINANCIALS Building and END MARKET REVENUE $2,355M $402M $1,300M $272M Sales EBITDA Specialty Engineered Materials Color Additives and Inks $592M$3,653M (1) 9% 32 (1) Total company sales and adjusted EBITDA of $3,653M and $592M, respectively, include intercompany sales eliminations and corporate costs 2022 REVENUE | $2 .4 BILLION US & Canada 34% 38% END MARKET REGION 33 34% 21% Building & 1% Energy 2% COLOR, ADDITIVES & INKS 2022 PRO FORMA REVENUE | $1 .3 BILLION US & Canada 52% 35% 34 19% 8%Industrial 16% 9% Defense Building & END MARKET REGION SPECIALTY ENGINEERED MATERIALS 32% 27% 14% Building & 3% 1% Defense 1% (18% of sales) 9% 2022 PROFORMA AVIENT REGIONAL SALES 27% 14% 17% Building & (37% of sales)Transportation 12% Building & US & Canada (40% of sales) 7% 56% 23% 7% Building & 1% LATAM (5% of sales) 3% 35 BY END MARKET Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.

Rose Vice President, Corporate Communications Avient Corporation +1 440-930-3162 kyle.rose@avient.com https://www.avient.com/news 7 Attachment 1 Avient Corporation Summary of Condensed Consolidated Statements of Income (Unaudited) (In millions, except per share data) Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Sales $ 823.3 $ 818.0 $ 2,606.5 $ 2,508.5 Operating Income 40.6 52.8 242.9 229.6 Net (loss) income from continuing operations attributable to Avient shareholders (27.4) 33.7 99.8 143.3 Basic (loss) earnings per share from continuing operations attributable to Avient shareholders $ (0.30) $ 0.37 $ 1.09 $ 1.57 Diluted (loss) earnings per share from continuing operations attributable to Avient shareholders $ (0.30) $ 0.37 $ 1.08 $ 1.56 Senior management uses comparisons of adjusted net income attributable to Avient shareholders and diluted adjusted earnings per share (EPS) attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results. Three Months Ended September 30, 2022 Three Months Ended September 30, 2021 Reconciliation to Condensed Consolidated Statements of Income $ EPS $ EPS Net (loss) income from continuing operations attributable to Avient shareholders $ (27.4) $ (0.30) $ 33.7 $ 0.37 Special items, after tax (Attachment 3) 68.3 0.75 11.7 0.13 Amortization expense, after-tax 13.4 0.14 $ 11.0 $ 0.11 Adjusted net income / EPS $ 54.3 $ 0.59 $ 56.4 $ 0.61 Nine Months Ended September 30, 2022 Nine Months Ended September 30, 2021 Reconciliation to Condensed Consolidated Statements of Income $ EPS $ EPS Net income from continuing operations attributable to Avient shareholders $ 99.8 $ 1.08 $ 143.3 $ 1.56 Special items, after tax (Attachment 3) 77.9 0.85 26.0 0.28 Amortization expense, after-tax 34.9 0.38 $ 33.6 0.36 Adjusted net income / EPS $ 212.6 $ 2.31 $ 202.9 $ 2.20 8 Attachment 2 Avient Corporation Condensed Consolidated Statements of Income (Unaudited) (In millions, except per share data) Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Sales $ 823.3 $ 818.0 $ 2,606.5 $ 2,508.5 Cost of sales 627.9 602.4 1,895.8 1,781.2 Gross margin 195.4 215.6 710.7 727.3 Selling and administrative expense 154.8 162.8 467.8 497.7 Operating income 40.6 52.8 242.9 229.6 Interest expense, net (37.3) (19.0) (70.4) (57.8) Other (expense) income, net (32.3) 1.6 (31.3) 4.3 (Loss) income from continuing operations before income taxes (29.0) 35.4 141.2 176.1 Income tax benefit (expense) 1.2 (2.0) (41.5) (32.1) Net (loss) income from continuing operations (27.8) 33.4 99.7 144.0 Income from discontinued operations, net of income taxes 17.1 19.2 58.8 57.7 Net (loss) income (10.7) 52.6 158.5 201.7 Net loss (income) attributable to noncontrolling interests 0.4 0.3 0.1 (0.7) Net (loss) income attributable to Avient common shareholders $ (10.3) $ 52.9 $ 158.6 $ 201.0 (Loss) earnings per share attributable to Avient common shareholders - Basic: Continuing operations $ (0.30) $ 0.37 $ 1.09 $ 1.57 Discontinued operations 0.19 0.21 0.65 0.63 Total $ (0.11) $ 0.58 $ 1.74 $ 2.20 (Loss) earnings per share attributable to Avient common shareholders - Diluted: Continuing operations $ (0.30) $ 0.37 $ 1.08 $ 1.56 Discontinued operations 0.19 0.20 0.64 0.62 Total $ (0.11) $ 0.57 $ 1.72 $ 2.18 Cash dividends declared per share of common stock $ 0.2375 $ 0.2125 $ 0.7125 $ 0.6375 Weighted-average shares used to compute earnings per common share: Basic 90.9 91.4 91.3 91.3 Diluted 90.9 92.2 92.0 92.1 9 Attachment 3 Avient Corporation Summary of Special Items (Unaudited) (In millions, except per share data) Special items (1) Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Cost of sales: Restructuring costs, including accelerated depreciation $ (2.8) $ (5.3) $ (9.8) $ (8.6) Environmental remediation costs (18.8) (9.4) (23.8) (22.4) Reimbursement of previously incurred environmental costs 0.1 — 8.3 4.5 Acquisition related costs (10.3) (2.6) (10.3) (1.2) Impact on cost of sales (31.8) (17.3) (35.6) (27.7) Selling and administrative expense: Restructuring, legal and other (0.2) — — (1.7) Acquisition related costs (8.2) (2.7) (13.2) (7.2) Impact on selling and administrative expense (8.4) (2.7) (13.2) (8.9) Impact on operating income (40.2) (20.0) (48.8) (36.6) Interest expense, net - costs related to committed financing (10.0) — (10.0) — Mark-to-market on derivative instruments (31.8) — (30.9) — Other — 0.1 0.1 0.1 Impact on other (expense)/income, net (31.8) 0.1 (30.8) 0.1 Impact on income from continuing operations before income taxes (82.0) (19.9) (89.6) (36.5) Income tax benefit on above special items 20.5 4.6 22.5 8.9 Tax adjustments(2) (6.8) 3.6 (10.8) 1.6 Impact of special items on net income from continuing operations $ (68.3) $ (11.7) $ (77.9) $ (26.0) Diluted earnings per common share impact $ (0.75) $ (0.13) $ (0.85) $ (0.28) Weighted average shares used to compute adjusted earnings per share: Diluted 91.6 92.2 92.0 92.1 (1) Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt extinguishment costs; costs incurred directly in relation to acquisitions or divestitures; employee separation costs resulting from personnel reduction programs, plant realignment costs, executive separation agreements; asset impairments; settlement gains or losses and mark-to- market adjustments associated with actuarial gains and losses on pension and other post-retirement benefit plans; environmental remediation costs, fines, penalties and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on the divestiture of operating businesses, joint ventures and equity investments; gains and losses on facility or property sales or disposals; results of litigation, fines or penalties, where such litigation (or action relating to the fines or penalties) arose prior to the commencement of the performance period; one-time, non-recurring items; and the effect of changes in accounting principles or other such laws or provisions affecting reported results Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Sales: Color, Additives and Inks $ 565.6 $ 586.6 $ 1,864.2 $ 1,820.3 Specialty Engineered Materials 258.2 231.7 743.6 685.3 Corporate and eliminations (0.5) (0.3) (1.3) 2.9 Sales $ 823.3 $ 818.0 $ 2,606.5 $ 2,508.5 Gross margin: Color, Additives and Inks $ 161.3 $ 172.1 $ 546.8 $ 563.0 Specialty Engineered Materials 66.9 61.4 201.3 192.6 Corporate and eliminations (32.8) (17.9) (37.4) (28.3) Gross margin $ 195.4 $ 215.6 $ 710.7 $ 727.3 Selling and administrative expense: Color, Additives and Inks $ 92.7 $ 105.3 $ 290.1 $ 321.1 Specialty Engineered Materials 35.5 31.4 96.4 94.2 Corporate and eliminations 26.6 26.1 81.3 82.4 Selling and administrative expense $ 154.8 $ 162.8 $ 467.8 $ 497.7 Operating income: Color, Additives and Inks $ 68.6 $ 66.8 $ 256.7 $ 241.9 Specialty Engineered Materials 31.4 30.0 104.9 98.4 Corporate and eliminations (59.4) (44.0) (118.7) (110.7) Operating income $ 40.6 $ 52.8 $ 242.9 $ 229.6 Depreciation & amortization: Color, Additives and Inks $ 24.2 $ 26.6 $ 76.1 $ 79.2 Specialty Engineered Materials 12.9 7.9 28.4 23.8 Corporate and eliminations 2.7 2.1 9.2 4.1 Depreciation & Amortization $ 39.8 $ 36.6 $ 113.7 $ 107.1 Earnings before interest, taxes, depreciation and amortization (EBITDA): Color, Additives and Inks $ 92.8 $ 93.4 $ 332.8 $ 321.1 Specialty Engineered Materials 44.3 37.9 133.3 122.2 Corporate and eliminations (56.7) (41.9) (109.5) (106.6) Other (expense) income, net (32.3) 1.6 (31.3) 4.3 EBITDA $ 48.1 $ 91.0 $ 325.3 $ 341.0 13 Attachment 7 Avient Corporation Reconciliation of Non-GAAP Financial Measures (Unaudited) (In millions, except per share data) Senior management uses gross margin before special items and operating income before special items to assess performance and allocate resources because senior management believes that these measures are useful in understanding current profitability levels and how it may serve as a basis for future performance.

Rose Vice President, Marketing and Communications Avient Corporation +1 440-930-3162 kyle.rose@avient.com mailto:giuseppe.disalvo@avient.com mailto:kyle.rose@avient.com 6 Attachment 1 Avient Corporation Summary of Condensed Consolidated Statements of Income (Unaudited) (In millions, except per share data) Three Months Ended December 31, Year Ended December 31, 2023 2022 2023 2022 Sales $ 719.0 $ 790.4 $ 3,142.8 $ 3,396.9 Operating income 43.1 0.4 196.8 243.3 Net income (loss) from continuing operations attributable to Avient shareholders 27.8 (17.0) 75.8 82.8 Diluted earnings (loss) per share from continuing operations attributable $ 0.30 $ (0.19) $ 0.83 $ 0.90 Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results. Three Months Ended December 31, 2023 2022 Reconciliation to Condensed Consolidated Statements of Income $ EPS(1) $ EPS(1) Net income (loss) from continuing operations attributable to Avient shareholders $ 27.8 $ 0.30 $ (17.0) $ (0.19) Special items, after tax (Attachment 3) 5.4 0.06 38.3 0.42 Amortization expense, after-tax 15.0 0.16 14.6 0.16 Adjusted net income / EPS $ 48.2 $ 0.52 $ 35.9 $ 0.39 (1) Per share amounts may not recalculate from figures presented herein due to rounding Year Ended December 31, 2023 2022 Reconciliation to Condensed Consolidated Statements of Income $ EPS(1) $ EPS(1) Net income from continuing operations attributable to Avient shareholders $ 75.8 $ 0.83 $ 82.8 $ 0.90 Special items, after tax (Attachment 3) 79.3 0.86 116.2 1.26 Amortization expense, after-tax 61.5 0.67 49.0 0.53 Adjusted net income / EPS $ 216.6 $ 2.36 $ 248.0 $ 2.69 (1) Per share amounts may not recalculate from figures presented herein due to rounding 7 Attachment 2 Avient Corporation Condensed Consolidated Statements of Income (Unaudited) (In millions, except per share data) Three Months Ended December 31, Year Ended December 31, 2023 2022 2023 2022 Sales $ 719.0 $ 790.4 $ 3,142.8 $ 3,396.9 Cost of sales 510.1 618.4 2,250.3 2,514.2 Gross margin 208.9 172.0 892.5 882.7 Selling and administrative expense 165.8 171.6 695.7 639.4 Operating income 43.1 0.4 196.8 243.3 Interest expense, net (26.8) (49.4) (115.3) (119.8) Other income (expense), net 4.3 (28.4) 5.8 (59.7) Income (loss) from continuing operations before income taxes 20.6 (77.4) 87.3 63.8 Income tax benefit (expense) 7.0 60.8 (11.0) 19.3 Net income (loss) from continuing operations 27.6 (16.6) 76.3 83.1 Income (loss) from discontinued operations, net of income taxes 0.8 561.5 (0.1) 620.3 Net income 28.4 544.9 76.2 703.4 Net loss (income) attributable to noncontrolling interests 0.2 (0.4) (0.5) (0.3) Net income attributable to Avient common shareholders $ 28.6 $ 544.5 $ 75.7 $ 703.1 Earnings (loss) per share attributable to Avient common shareholders - Basic: Continuing operations $ 0.30 $ (0.19) $ 0.83 $ 0.91 Discontinued operations 0.01 6.17 — 6.80 Total $ 0.31 $ 5.98 $ 0.83 $ 7.71 Earnings (loss) per share attributable to Avient common shareholders - Diluted: Continuing operations $ 0.30 $ (0.19) $ 0.83 $ 0.90 Discontinued operations 0.01 6.17 — 6.73 Total $ 0.31 $ 5.98 $ 0.83 $ 7.63 Cash dividends declared per share of common stock $ 0.2575 $ 0.2475 $ 1.0000 $ 0.9600 Weighted-average shares used to compute earnings per common share: Basic 91.2 91.0 91.1 91.2 Diluted 91.9 91.0 91.8 92.2 8 Attachment 3 Avient Corporation Summary of Special Items (Unaudited) (In millions, except per share data) Special items (1) Three Months Ended December 31, Year Ended December 31, 2023 2022 2023 2022 Cost of sales: Restructuring costs, including accelerated depreciation $ (2.0) $ (21.3) $ (11.9) $ (31.1) Environmental remediation costs (17.2) (0.4) (69.7) (24.2) Reimbursement of previously incurred environmental costs 1.6 — 1.6 8.3 Acquisition related costs — (23.8) — (34.1) Impact on cost of sales (17.6) (45.5) (80.0) (81.1) Selling and administrative expense: Restructuring and employee separation costs (1.1) (4.3) (14.9) (5.3) Legal and other (6.1) (4.0) (15.2) (3.0) Acquisition related costs (1.3) (6.1) (5.9) (19.3) Impact on selling and administrative expense (8.5) (14.4) (36.0) (27.6) Impact on operating income (26.1) (59.9) (116.0) (108.7) Interest expense, net - financing costs (0.1) (16.0) (2.3) (26.0) Mark-to-market on derivatives — — — (30.9) Pension and post retirement mark-to-market adjustment and other 3.8 (28.4) 3.7 (28.4) Impact on other income (expense), net 3.8 (28.4) 3.7 (59.3) Impact on income from continuing operations before income taxes (22.4) (104.3) (114.6) (194.0) Income tax benefit on above special items 4.5 26.8 27.7 49.4 Tax adjustments(2) 12.5 39.2 7.6 28.4 Impact of special items on net income from continuing operations $ (5.4) $ (38.3) $ (79.3) $ (116.2) Diluted earnings per common share impact $ (0.06) $ (0.42) $ (0.86) $ (1.26) Weighted average shares used to compute adjusted earnings per share: Diluted 91.9 91.7 91.8 92.2 (1) Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt extinguishment costs; costs incurred directly in relation to acquisitions or divestitures; employee separation costs resulting from personnel reduction programs, plant realignment costs, executive separation agreements; asset impairments; settlement gains or losses and mark-to- market adjustments associated with gains and losses on pension and other post-retirement benefit plans; environmental remediation costs, fines, penalties and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on the divestiture of operating businesses, gains and losses on facility or property sales or disposals; results of litigation, fines or penalties, where such litigation (or action relating to the fines or penalties) arose prior to the commencement of the performance period; one-time, non- recurring items; and the effect of changes in accounting principles or other such laws or provisions affecting reported results Three Months Ended December 31, Year Ended December 31, 2023 2022 2023 2022 Sales: Color, Additives and Inks $ 459.4 $ 490.8 $ 2,007.4 $ 2,355.0 Specialty Engineered Materials 259.8 300.8 1,138.2 1,044.4 Corporate (0.2) (1.2) (2.8) (2.5) Sales $ 719.0 $ 790.4 $ 3,142.8 $ 3,396.9 Gross margin: Color, Additives and Inks $ 148.3 $ 134.5 $ 631.2 $ 681.3 Specialty Engineered Materials 78.1 82.4 341.8 283.7 Corporate (17.5) (44.9) (80.5) (82.3) Gross margin $ 208.9 $ 172.0 $ 892.5 $ 882.7 Selling and administrative expense: Color, Additives and Inks $ 86.5 $ 90.2 $ 371.3 $ 380.3 Specialty Engineered Materials 48.7 47.2 199.3 143.6 Corporate 30.6 34.2 125.1 115.5 Selling and administrative expense $ 165.8 $ 171.6 $ 695.7 $ 639.4 Operating income: Color, Additives and Inks $ 61.8 $ 44.3 $ 259.9 $ 301.0 Specialty Engineered Materials 29.4 35.2 142.5 140.1 Corporate (48.1) (79.1) (205.6) (197.8) Operating income $ 43.1 $ 0.4 $ 196.8 $ 243.3 13 Attachment 7 Avient Corporation Reconciliation of Non-GAAP Financial Measures (Unaudited) (In millions, except per share data) Senior management uses gross margin before special items and operating income before special items to assess performance and allocate resources because senior management believes that these measures are useful in understanding current profitability levels and how it may serve as a basis for future performance.